1. Wang, Ying-Bin, Zhang, Rong-Zhi, Huang, Sheng-Hui, Wang, Shu-Bao, Xie, Jian-Qin. 2017. Relationship between UGT1A9 gene polymorphisms, efficacy, and safety of propofol in induced abortions amongst Chinese population: a population-based study. In Bioscience reports, 37, . doi:10.1042/BSR20170722. https://pubmed.ncbi.nlm.nih.gov/28899924/
2. Girard, Hugo, Court, Michael H, Bernard, Olivier, Perussed, Louis, Guillemette, Chantal. . Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. In Pharmacogenetics, 14, 501-15. doi:. https://pubmed.ncbi.nlm.nih.gov/15284532/
3. Annisa, Nurul, Barliana, Melisa I, Santoso, Prayudi, Ruslami, Rovina. 2022. Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parameters. In Frontiers in pharmacology, 13, 1063413. doi:10.3389/fphar.2022.1063413. https://pubmed.ncbi.nlm.nih.gov/36588725/
4. Fujita, Ken-ichi, Ando, Yuichi, Nagashima, Fumio, Narabayashi, Masaru, Sasaki, Yasutsuna. . Novel single nucleotide polymorphism of UGT1A9 gene in Japanese. In Drug metabolism and pharmacokinetics, 21, 79-81. doi:. https://pubmed.ncbi.nlm.nih.gov/16547398/
5. Barbier, Olivier, Girard, Hugo, Inoue, Yusuke, Gonzalez, Frank J, Staels, Bart. 2004. Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alpha. In Molecular pharmacology, 67, 241-9. doi:. https://pubmed.ncbi.nlm.nih.gov/15470081/
6. Pavlovic, Dimitrije, Budic, Ivana, Jevtovic Stoimenov, Tatjana, Slavkovic, Milan, Simic, Dusica. 2020. The Effect of UGT1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children. In Pharmacogenomics and personalized medicine, 13, 13-27. doi:10.2147/PGPM.S231329. https://pubmed.ncbi.nlm.nih.gov/32021384/
智鼠故事 
